Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity
Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older
Family History of BRCA Mutation Does Not Equal Increased Risk
Daily Vitamin E Supplements Can Lead to Increased PCa Risk
Digital Immunoassay PSA Test May Predict Cancer Recurrence
Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV
Researchers Discover Bacteria Common in Colon Cancer Tissue
Colon Cancer Survival Rates Differ Across Racial Lines
NCI Predicts 42 Percent Increase In Number of Senior Survivors
IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer
NCI CTEP: Approved Trials For The Month of October
FDA Grants Accelerated Approval To Ferriprox for Iron Overload
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- How will FDA regulate psychedelics?
- The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long” - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- The future of oncology: Early-career scientists need mentorship and a new academic model
- OMB proposal to sideline peer review sparks widespread opposition
Nearly 500,000 public comments flood in—here are some highlights
